Cost-effectiveness of acupuncture treatment in patients with chronic neck pain

Pain

Volumn 125, Issue 1-2, 2006, Pages 107-113

  Willich, Stefan N ^a   Reinhold, Thomas ^a   Selim, Dagmar ^a   Jena, Susanne ^a   Brinkhaus, Benno ^a   Witt, Claudia M ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Acupuncture; Chronic neck pain; Cost effectiveness analysis; Economic evaluation; Net health benefit; Routine care

Indexed keywords

ACUPUNCTURE; ADULT; AGED; ARTICLE; CHRONIC PAIN; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FEMALE; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; MALE; NECK PAIN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SOCIAL INSURANCE; THERAPY EFFECT;

ACTIVITIES OF DAILY LIVING; ACUPUNCTURE THERAPY; CHRONIC DISEASE; COST-BENEFIT ANALYSIS; DISABILITY EVALUATION; FEMALE; GERMANY; HEALTH CARE COSTS; HEALTH EXPENDITURES; HUMANS; MALE; MIDDLE AGED; NECK PAIN; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME;

EID: 33749334608     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pain.2006.06.006     Document Type: Article

References (25)

1. Borghouts J.A., Koes B.W., Vondeling H., and Bouter L.M. Cost-of-illness of neck pain in The Netherlands in 1996. Pain 80 (1999) 629-636
2. Brazier J., Roberts J., and Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ 21 (2002) 271-292
3. Brinkhaus B., Becker-Witt C., Jena S., Linde K., Streng A., Wagenpfeil S., et al. Acupuncture Randomized Trials (ART) in patients with chronic low back pain and osteoarthritis of the knee - design and protocols. Forsch Komplementärmed Klass Naturheilkd 10 (2003) 185-191
4. Brinkhaus B., Witt C.M., Jena S., Linde K., Streng A., Wagenpfeil S., et al. Acupuncture in patients with chronic low back pain - a randomised controlled trial. Arch Intern Med 166 (2006) 450-457
5. Bullinger M., and Kirchberger I. SF-36 Fragebogen zum Gesundheitszustand (1998), Hogrefe, Göttingen
6. Claxton K. The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies. J Health Econ 18 (1999) 341-364
7. Coyle D., and Tolley K. Discounting of health benefits in the pharmacoeconomic analysis of drug therapies: an issue for debate?. Pharmacoeconomics 2 (1992) 153-162
8. Eisenberg D.M., Davis R.B., Ettner S.L., Appel S., Wilkey S., Van-Rompay M., et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. J Am Med Assoc 280 (1998) 1569-1575
9. Federal statistical department Germany. population health insurance coverage, Germany 2003. statistical annual for Germany 2004 Federal statistical department Germany Wiesbaden, 2004.
10. Hanoverian Consensus-Group. German Recommendations for health economic evaluations - revised version of the Hanover Consensus. (Deutsche Empfehlungen zur gesundheitsökonomischen Evaluation - Revidierte Fassung des Hanoveraner Konsens). Gesundh Ökon Qual Manag 1999;4:A62-5.
11. Härtel U., and Volger E. Inanspruchnahme und Akzeptanz klassischer Naturheilverfahren und alternativer Heilmethoden in Deutschland - Ergebnisse einer reprasentativen Bevolkerungsstudie. Forsch Komplementarmed Klass Naturheilkd 11 (2004) 327-334
12. Lothgren M., and Zethraeus N. Definition, interpretation and calculation of cost-effectiveness acceptability curves. Health Econ 9 (2000) 623-630
13. Paterson C., and Britten N. Acupuncture as a complex intervention: a holistic model. J Altern Complement Med 10 (2004) 791-801
14. Pickard A.S., Wang Z., Walton S.M., and Lee T.A. Are decisions using cost-utility analyses robust to choice of SF-36/SF-12 preference-based algorithm?. Health Qual Life Outcomes 3 (2005) 11
15. Raftery J. NICE: faster access to modern treatments? Analysis of guidance on health technologies. Br Med J 323 (2001) 1300-1303
16. Richardson G., and Manca A. Calculation of quality adjusted life years in the published literature: a review of methodology and transparency. Health Econ 13 (2004) 1203-1210
17. Rivero-Arias O., Campbell H., Gray A., Fairbank J., Frost H., and Wilson-MacDonald J. Surgical stabilisation of the spine compared with a programme of intensive rehabilitation for the management of patients with chronic low back pain: cost utility analysis based on a randomised controlled trial. Br Med J 330 (2005) 1239
18. Thomas K.J., MacPherson H., Ratcliffe J., Thorpe L., Brazier J., Campbell M., et al. Longer term clinical and economic benefits of offering acupuncture care to patients with chronic low back pain. Health Technol Assess 9 (2005) iii-x 1
19. Thomas K.J., Nicholl J.P., and Coleman P. Use and expenditure on complementary medicine in England: a population based survey. Complement Ther Med 9 (2001) 2-11
20. Thompson S.G., and Barber J.A. How should cost data in pragmatic randomised trials be analysed?. Br Med J 320 (2000) 1197-1200
21. Wheeler A.H., Goolkasian P., Baird A.C., and Darden B.V. Development of the Neck Pain and Disability Scale. Item analysis, face, and criterion-related validity. Spine 24 (1999) 1290-1294
22. Williams N.H., Edwards R.T., Linck P., Muntz R., Hibbs R., Wilkinson C., et al. Cost-utility analysis of osteopathy in primary care: results from a pragmatic randomized controlled trial. Fam Pract 21 (2004) 643-650
23. Witt C., Brinkhaus B., Jena S., Linde K., Streng A., Wagenpfeil S., et al. Acupuncture in patients with osteoarthritis of the knee - a randomised trial. Lancet 366 9480 (2005) 136-143
24. Wonderling D., Vickers A.J., Grieve R., and McCarney R. Cost effectiveness analysis of a randomised trial of acupuncture for chronic headache in primary care. Br Med J 328 (2004) 747-749
25. Zethraeus N., Johannesson M., Jonsson B., Lothgren M., and Tambour M. Advantages of using the net-benefit approach for analysing uncertainty in economic evaluation studies. Pharmacoeconomics 21 (2003) 39-48